Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma


SOYDAL Ç., ÖZKAN E., Nak D., ELHAN A. H., Kucuk N., KIR K. M.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, cilt.44, 2017 (SCI-Expanded) identifier